Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs Ensysce Biosciences, Inc. (ENSC)

A side-by-side comparison of Cuprina Holdings (Cayman) Limited Class A Ordinary Shares and Ensysce Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares logo
CUPR
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
$6M
$2.20HealthcareDelayed quote: Oct 6, 2026, 9:53 AM EDT
Ensysce Biosciences, Inc. logo
ENSC
Ensysce Biosciences, Inc.
$7M
$0.43HealthcareDelayed quote: Oct 6, 2026, 10:00 AM EDT

Total return — CUPR vs ENSC

growth of $100 · dividends reinvested · last 1y
CUPR -93.2% (-93.2%/yr)ENSC -77.7% (-77.7%/yr)ENSC compounded faster over this window
050100150200Start $1002026$7$22
CUPR ENSC

CUPR vs ENSC: by the numbers

  • •ENSC is the larger company ($7M vs $6M market cap).
  • •Both run net losses; ENSC's is the smaller (-1084.23% vs -9366.75% net margin).

Metrics side by side

Valuation

MetricCUPRENSC
P/S ratioN/A5.64
P/B ratio1.50N/A

Profitability

MetricCUPRENSC
Gross margin-1.29%0.00%
Operating margin-9154.62%0.00%
Net margin-9366.75%-1084.23%
ROE-92.44%N/A
ROIC-84.15%N/A

Growth (annualized)

MetricCUPRENSC
Total return CAGR (5Y)N/A-86.22%

Go deeper

Full CUPR analysisFull ENSC analysisInteractive comparison tool

Dig into the metrics

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares ROEEnsysce Biosciences ROECuprina Holdings (Cayman) Limited Class A Ordinary Shares operating marginEnsysce Biosciences operating marginCuprina Holdings (Cayman) Limited Class A Ordinary Shares revenue growthEnsysce Biosciences revenue growthCuprina Holdings (Cayman) Limited Class A Ordinary Shares free cash flowEnsysce Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.